Skepticism on Mouse-Based Longevity Treatments
D
Doctor Adam Bataineh on Ben Kelly's podcast
Anti-AgingMedical
Story of claim
Dr. Bataineh expresses skepticism about the efficacy of longevity treatments effective in mice translating to humans, citing that 90% of basic research in mice does not apply to humans.
- Goal: To assess the validity and applicability of translating mouse-based longevity treatments to humans.
- Proof: 90% of basic research doesn't translate to humans, highlighting skepticism.
- Nuances:
- Rapamycin shown to extend lifespan, unlike NMN.
- Interventions in mice often lack human efficacy evidence.
- Impact on Life: Increased awareness and critical assessment of longevity research in humans.
Investments
- Price: Estimated at $0
- Time: No direct time investment required
- Effort: Effort involved in staying updated with research developments
Risks
Potential misallocation of resources in ineffective human treatments based on mouse studies.
Get Started 🚀
- Read scientific literature on longevity treatments.
- Critically evaluate new longevity claims.
- Discuss with experts before considering treatments.
Brogevity AI can make mistakes. Check important info.